NCT01624870View on ClinicalTrials.gov

CoreValve Advance-II Study: Prospective International Post-market Study

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

March 31, 2014

Conditions
Aortic Valve StenosisValvular Heart Disease
Trial Locations (9)

2650

Universitair Ziekenhuis Antwerpen, Edegem

10117

Charite, Campus Mitte - Kardiologie Berlin, Berlin

20149

Istituto Clinico S. Ambrogio, Milan

53127

Universitätsklinikum Bonn, Bonn

56100

Azienda Ospedaliero Universitaria Pisana, Pisa

69120

Universitätsklinikum Heidelberg, Heidelberg

73961

Nemocnice Podlesi Trinec, Třinec

3015 CE

Erasmus Medical Center Rotterdam, Rotterdam

Le3 9 QP

Glenfield Hospital Leicester, Leicester

All Listed Sponsors
lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT01624870 - CoreValve Advance-II Study: Prospective International Post-market Study | Biotech Hunter | Biotech Hunter